Clinical experience of a new inotropic agent--Prenalterol--in hypotension and heart failure.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000767:Anesthesia, Epidural; D002303:Cardiac Output, Low / Q000188:drug therapy / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011217:Practolol / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D011294:Prenalterol; D012772:Shock, Septic / Q000188:drug therapy / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents; D011294:Prenalterol; D011217:Practolol